Streetbeat News

Products Services

STN

A report by the Centre for Economics and Business Research and Stantec suggests that BT Group's Openreach broadband rollout could boost the UK economy by £66 billion by 2029, enhancing productivity and enabling more people to return to work.

Portfolio Pulse from

November 25, 2024 | 9:00 am

EW

Edwards Lifesciences announced positive one-year data for its SAPIEN 3 Ultra RESILIA valve, showing excellent outcomes in over 9,000 patients. The data was presented at PCR London Valves 2024 and published in JACC: Cardiovascular Interventions.

Portfolio Pulse from

November 25, 2024 | 8:45 am

BYDDY

BYD, a major player in the electric vehicle industry, announced plans to launch a new generation of blade batteries in 2025. This development was reported by Chinese state media CGTN.

Portfolio Pulse from

November 25, 2024 | 8:30 am

DTCFF

Defence Therapeutics Inc., a Canadian biopharmaceutical company, has appointed Dr. Maxime Parisotto as Chief Scientific Officer and Director of Science and Business Development. Dr. Parisotto brings over 20 years of experience in biochemistry, drug development, and innovation to the company.

Portfolio Pulse from

November 25, 2024 | 8:30 am

TROYF

Troy Minerals Inc. has completed a LiDAR survey at its Table Mountain Silica Project in British Columbia, indicating potential for high-purity silica mineralization.

Portfolio Pulse from

November 25, 2024 | 8:30 am

AZN

AstraZeneca's prostate cancer drug Truqap (capivasertib) has shown promising results in a phase III trial, improving progression-free survival in patients with PTEN-deficient metastatic hormone-sensitive prostate cancer.

Portfolio Pulse from

November 25, 2024 | 8:15 am

RIO

ElectraLith, a lithium start-up backed by Rio Tinto, plans to raise AU$29 million to further develop its innovative lithium extraction technology.

Portfolio Pulse from

November 25, 2024 | 8:15 am

GSK

GSK has submitted an application to the FDA for the approval of Blenrep, a treatment for relapsed or refractory multiple myeloma. If approved, it could be used in combination with other drugs for patients who have undergone prior therapy.

Portfolio Pulse from

November 25, 2024 | 8:15 am

BNXTF

BioNxt Solutions Inc. has announced the expansion of its product pipeline, focusing on innovative drug delivery systems for autoimmune diseases and the longevity market.

Portfolio Pulse from

November 25, 2024 | 8:15 am

GM

General Motors is highlighted as a top pick for 2025 on Seeking Alpha's Quant Dean's List due to its strong performance in valuation, growth, profitability, momentum, and EPS revisions. The company's improving EV momentum and solid financial performance make it an attractive investment.

Portfolio Pulse from

November 25, 2024 | 8:15 am